SCHEMBL16782007

SCHEMBL16782007

N#Cc1ccc(NC(=O)Nc2cccc(Cl)c2)cc1

nearest known ligand 0.75

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 9/20 0.75
KMT2A Q03164 9/20 0.75
MAPT P10636 8/20 0.75
ALDH1A1 P00352 3/20 0.75
LMNA P02545 6/20 0.71
HTT P42858 4/20 0.71
TSHR P16473 2/20 0.71
NLRP3 Q96P20 1/20 0.71
RAB9A P51151 6/20 0.69
NPC1 O15118 5/20 0.69
KDM4E B2RXH2 2/20 0.64
GAA P10253 1/20 0.64
ALOX15 P16050 1/20 0.64
HSD17B10 Q99714 1/20 0.64
MAOB P27338 1/20 0.64
SMN1; SMN2 Q16637 2/20 0.62
L3MBTL1 Q9Y468 2/20 0.61
TP53 P04637 1/20 0.61
NFKB1 P19838 1/20 0.61
NFKB2 Q00653 1/20 0.61

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27371332 0.89 MEN1 (0.72) MEN1KMT2AMAPTALDH1A1LMNA
SCHEMBL20941580 0.88 MAOB (0.61) MEN1KMT2AMAPTALDH1A1LMNA
SCHEMBL7248947 0.86 MAPT (1.00) MEN1KMT2AMAPTALDH1A1LMNA
SCHEMBL4116856 0.84 MAPT (1.00) MEN1KMT2AMAPTALDH1A1LMNA
SCHEMBL11049956 0.84 MEN1 (0.85) MEN1KMT2AMAPTALDH1A1LMNA
SCHEMBL2682054 0.83 KMT2A (1.00) MEN1KMT2AMAPTALDH1A1LMNA
SCHEMBL10344695 0.82 MEN1 (1.00) MEN1KMT2AMAPTALDH1A1LMNA
SCHEMBL29533340 0.82 MEN1 (1.00) MEN1KMT2AMAPTALDH1A1LMNA
SCHEMBL11056656 0.82 MAPT (0.75) MEN1KMT2AMAPTALDH1A1LMNA
SCHEMBL27884751 0.82 MEN1 (0.75) MEN1KMT2AMAPTALDH1A1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2024006055-A1 SMALL MOLECULE BROAD-SPECTRUM ANTIBIOTICS UNIVERSITY OF FLORIDA RESEARCH FOUNDATION, INCORPORATED (US) 2024-01-04 WO disclosed
US-20150150878-A1 Methods For Inhibiting Viruses By Targeting Cathepsin-L Cleavage Sites In The Viruses' Glycoproteins THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ILLINOIS 2015-06-04 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150150878-A1 Methods For Inhibiting Viruses By Targeting Cathepsin-L Cleavage Sites In The Viruses' Glycoproteins CTSL, CTSH, CTSV MEN1 4435/4885KMT2A 4587/4885MAPT 3447/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.